Hematology

AMSBIO has announced two new histone deacetylase (HDAC) cell-based assay kits that provide a tool for studying the activity and inhibition of the full range of HDAC enzymes (1 to 11).

Asuragen launches multi-center collaboration for development of diagnostic test for pancreatic cancer

Pharmaceutical manufacturers are under increased pressure to differentiate new drugs from those already on the market.

Beckman Coulter Genomics partners with Genpathway to unravel complex DNA-protein interactions

Researchers at the University of Manchester and the University of Buffalo have discovered an enzyme that “cleans” cells of WT1, a gene that is believed to be responsible for a wide range of cancers

A group of researchers have discovered genetic mutations that may contribute to the development of an aggressive form of non- Hodgkin\'s lymphoma.

MIT and Alnylam researchers find way to turn off multiple genes at once with RNAi therapy

They aim to develop FLT3 kinase inhibitors for AML and more

Millipore sponsors three academic memberships for GeneGo’s MetaMiner Stem Cell project

Thermo Fisher Scientific Inc. also announced in December a collaboration between its Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and Expression Pathology Inc.

he Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG were fined a total of $5.7 million by competition regulators on Dec. 1 for alleged price-fixing of drugs for erectile dysfunction.

SurModics Inc., a provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced in November that they signed a license agreement for NP201, the first long-acting treatment available in broadly acceptable dose form that maintains the potential to provide sustained relief from Parkinson’s disease without motor response complications.